Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· May 25, 2026

Billionaire Bill Ackman Sold This Stock While Warren Buffett Successor Greg Abel Bought It. Who's Right?

View original at finance.yahoo.com
Billionaire Bill Ackman Sold This Stock While Warren Buffett Successor Greg Abel Bought It. Who's Right? Bill Ackman is one of the most followed investment managers in the market today, and for good reason…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Search revenue growth continues to accelerate, up 19% in the most recent quarter, driven by AI product improvements and underlying model advances

    60% confidence
  • Google Cloud revenue growth accelerated to 63% last quarter and operating margin expanded to 33%, with total operating income tripling

    60% confidence
  • Gemini family of models are among the most performant on the market

    60% confidence
  • Pershing Square Holdings produced annualized returns of 14.9% from founding in 2004 through 2025, handily beating the S&P 500

    60% confidence
  • Alphabet's AI models are better at understanding search intent, improving ad targeting

    60% confidence
  • AI Overview has led to significant increases in engagement while maintaining the same level of monetization

    60% confidence
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com
Billionaire Bill Ackman Sold This Stock While Warren Buffett Successor Greg Abel Bought It. Who's Right? — Source | Via News | ViaNews Market